Standigm and Protai Launch Joint R&D Program to Design Selective Molecular Glue Degraders Using Structural Proteomics and Generative AI

Korea-Israel collaboration, supported by KORIL-RDF, pairs Protai's AI-powered structural proteomics with Standigm's generative drug design to tackle selectivity - a central challenge in targeted protein degradation SEOUL, Republic of Korea and TEL AVIV, Israel, Sept. 16, 2026 /PRNewswire/...